MindBio Therapeutics Corp. C.MBIO

Where does the money come from?

[Smokey1958]

MBIO has to have significant research connections to move forward as quickly as they have been in branching out from Phase 1 to Phase 2 trials and already forecasting Phase 3 trials. The researchers dont only wait for money from public individual or institutional investors. As an example here is the research grant (government) awarded to Dr. Rachael Sumner two months ago that has no doubt led in part to the recent NRs. Congratulations to Dr Rachael Sumner who recently received an AMRF Postdoctoral Fellowship. She will receive $264,233 over the next 2 years for her on the work on the myriad of neurological and psychiatric disorders caused by, or made worse by, major changes in hormones around the menstrual cycle, pregnancy, and menopause.

[Sleepydog24]

Amazing info you provide Smoky ... I feel this is going to be trading on the Naz and be the twin of MindMed which is close to a $Billion marketcap Canadian... both at the same stages in clinical trials using their own proprietary formulation for LSD and both using it to treat different areas of depression ... hard to fathom how one can have an $8 million (MBIO) while the other sits near a $billion

[Smokey1958]

Absolutely true, Sleepydog! Mindbend has been at this for a little over 4 years which would explain the "current" difference in market cap. Being an American entity where 95% of their investors trade through one of the NASDAQ exchanges doesn't hurt either (10x the potential investors). As a consequence they just delisted from a Canadian exchange to cut costs etc and because of the